Abstract
Alzheimer's disease (AD) is a neurodegenerative disorder characterized by selective neuronal loss, amyloid plaques and neurofibrillary tangles. Oxidative stress may play an important role in the pathogenesis of AD which is associated with the accumulation of β-amyloid (Aβ). Jatrorrhizine (JAT) is a novel tetrahydroisoquinoline alkaloid originally extracted from the Chinese herb coptidis rhizome. Our previous studies showed that JAT protected neuronallike cells against H2O2 -induced toxicity. In this study, we investigated the protective effects of JAT against Aβ25-35- induced cell death in rat cortical neurons. When the cortical neurons were exposed to 25μM Aβ25-35 for 24h, there was a significant reduction in cell viability and activities of SOD and GSH-Px. It also increased the production of malondialdehyde (MDA) and ROS but reduced MMP. Pretreatment of the cortical neurons with various concentrations of JAT (1-10μM) attenuated Aβ25-35-induced neurotoxicity markedly. JAT was also showed to suppress the activation of caspase-3 induced by Aβ25-35 and prevented the cytochrome c transporting into the cytosol. These results indicate that JAT demonstrates the neuroprotective effects against Aβ25-35-induced injury via its antioxidative potential, which may provide a therapeutical potential to AD.
Keywords: β-amyloid (25-35), JAT, Alzheimer’s disease, oxidative stress, apoptosis, antioxidative potential, malondialdehyde, neurofibrillary tangles, neurotoxicity, cortical neurons.
CNS & Neurological Disorders - Drug Targets
Title:The Protective Effects of Jatrorrhizine on β-Amyloid (25-35)-Induced Neurotoxicity in Rat Cortical Neurons
Volume: 11 Issue: 8
Author(s): Tao Luo, Wei Jiang, Yan Kong, Sheng Li, Feng He, Jie Xu and Hua-Qiao Wang
Affiliation:
Keywords: β-amyloid (25-35), JAT, Alzheimer’s disease, oxidative stress, apoptosis, antioxidative potential, malondialdehyde, neurofibrillary tangles, neurotoxicity, cortical neurons.
Abstract: Alzheimer's disease (AD) is a neurodegenerative disorder characterized by selective neuronal loss, amyloid plaques and neurofibrillary tangles. Oxidative stress may play an important role in the pathogenesis of AD which is associated with the accumulation of β-amyloid (Aβ). Jatrorrhizine (JAT) is a novel tetrahydroisoquinoline alkaloid originally extracted from the Chinese herb coptidis rhizome. Our previous studies showed that JAT protected neuronallike cells against H2O2 -induced toxicity. In this study, we investigated the protective effects of JAT against Aβ25-35- induced cell death in rat cortical neurons. When the cortical neurons were exposed to 25μM Aβ25-35 for 24h, there was a significant reduction in cell viability and activities of SOD and GSH-Px. It also increased the production of malondialdehyde (MDA) and ROS but reduced MMP. Pretreatment of the cortical neurons with various concentrations of JAT (1-10μM) attenuated Aβ25-35-induced neurotoxicity markedly. JAT was also showed to suppress the activation of caspase-3 induced by Aβ25-35 and prevented the cytochrome c transporting into the cytosol. These results indicate that JAT demonstrates the neuroprotective effects against Aβ25-35-induced injury via its antioxidative potential, which may provide a therapeutical potential to AD.
Export Options
About this article
Cite this article as:
Luo Tao, Jiang Wei, Kong Yan, Li Sheng, He Feng, Xu Jie and Wang Hua-Qiao, The Protective Effects of Jatrorrhizine on β-Amyloid (25-35)-Induced Neurotoxicity in Rat Cortical Neurons, CNS & Neurological Disorders - Drug Targets 2012; 11 (8) . https://dx.doi.org/10.2174/1871527311211080013
DOI https://dx.doi.org/10.2174/1871527311211080013 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
Call for Papers in Thematic Issues
Diagnosis and treatment of central nervous system infectious diseases
Infectious diseases of the central nervous system (CNS) can be divided into bacterial, tuberculous, viral, fungal, parasitic infections, etc. Early etiological treatment is often the most crucial means to reduce the mortality rate of patients with central nervous system infections, reduce complications and sequelae, and improve prognosis. The initial clinical ...read more
Techniques of Drug Repurposing: Delivering a new life to Herbs & Drugs
Of late, with the adaptation of innovative approaches and integration of advancements made towards medical sciences as well as the availability of a wide range of tools; several therapeutic challenges are being translated into viable clinical solutions, with a high degree of efficacy, safety, and selectivity. With a better understanding ...read more
Trends and perspectives in the rational management of CNS disorders
Central nervous system (CNS) diseases enforce a significant global health burden, driving ongoing efforts to improve our understanding and effectiveness of therapy. This issue investigates current advances in the discipline, focusing on the understanding as well as therapeutic handling of various CNS diseases. The issue covers a variety of diseases, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Editorial [Hot Topic:Therapeutic Potential of Peptide Motifs - Part V (Executive Guest Editor: Jean-Claude Herve)]
Current Pharmaceutical Design Associations of Cerebrovascular and Alzheimer’s Disease Pathology with Brain Atrophy
Current Alzheimer Research Neurological Substrate of Central Auditory Processing Deficits in Children
Current Pediatric Reviews Quinazolines as Apoptosis Inducers and Inhibitors: A Review of Patent Literature
Recent Patents on Anti-Cancer Drug Discovery MicroRNAs: Macro Challenges on Understanding Human Biological Functions and Neurological Diseases
Current Molecular Medicine Vitamin D: Preventive and Therapeutic Potential in Parkinson’s disease
Current Drug Metabolism Strength and Weaknesses of Cerebrospinal Fluid Biomarkers in Alzheimer’s Disease and Possible Detection of Overlaps with Frailty Process
CNS & Neurological Disorders - Drug Targets Edaravone May Prevent Ferroptosis in ALS
Current Drug Targets Neurovascular Matrix Metalloproteinases and the Blood-Brain Barrier
Current Pharmaceutical Design The Role of Oxidative Stress in Depressive Disorders
Current Pharmaceutical Design New Insights into Endocannabinoid Degradation and its Therapeutic Potential
Mini-Reviews in Medicinal Chemistry Nanotechnology and Antioxidant Therapy: An Emerging Approach for Neurodegenerative Diseases
Current Medicinal Chemistry Non-Antidepressant Pharmacological Treatment of Obsessive Compulsive Disorder: A Comprehensive Review
Current Clinical Pharmacology The Immune Protective Effect of the Mediterranean Diet against Chronic Low-grade Inflammatory Diseases
Endocrine, Metabolic & Immune Disorders - Drug Targets Targeting the Alpha 7 Nicotinic Acetylcholine Receptor to Reduce Amyloid Accumulation in Alzheimers Disease Pyramidal Neurons
Current Pharmaceutical Design DNA Vaccine and the CNS Axonal Regeneration
Current Pharmaceutical Design High Doses of In vitro Beta-carotene, Alpha-Tocopherol and Ascorbic Acid Induce Oxidative Stress and Secretion of IL-6 in Peripheral Blood Mononuclear Cells from Healthy Donors
Current Aging Science Half a Century of l-DOPA
Current Topics in Medicinal Chemistry Relevance of Bioassay of Biologically Active Substances (BAS) with Geroprotective Properties in the Model of the Nematode <i>Caenorhabditis Elegans</i> in <i>In Vivo</i> Experiments
Current Aging Science Protein Kinase C-Related Kinase (PKN/PRK). Potential Key-Role for PKN1 in Protection of Hypoxic Neurons
Current Neuropharmacology